FDA-Cleared Clinical AI Platform Raises Questions About the Nature of the Decision Maker

UpDoc recently announced FDA clearance for what it describes as the first agentic clinical AI platform, but a closer look at the 510(k) documents reveals that the large language model serves as a data collection interface, not a decision maker, highlighting a growing gap between how clinical AI is marketed and how it's regulated.